ACE inhibitors/calcium antagonists overdoseHypotension and impaired renal perfusion: case report

被引：0

作者：

机构：

来源：

Reactions Weekly | 1997年 / 675卷 / 1期

关键词：

Dopamine; Angiotensin; Norepinephrine; Enalapril; Calcium Antagonist;

D O I：

10.2165/00128415-199706750-00010

中图分类号：

学科分类号：

摘要：

引用

页码：6 / 6

共 50 条

[41] Distinct time courses of renal protective action of angiotensin receptor antagonists and ACE inhibitors in chronic renal disease
H Matsuda
K Hayashi
T Saruta
[J]. Journal of Human Hypertension, 2003, 17 : 271 - 276
[42] INSITU RENAL PERFUSION - A CASE-REPORT
TIMMONS, SL
WARD, R
WHITE, RWD
[J]. WORLD JOURNAL OF UROLOGY, 1990, 8 (01) : 55 - 57
[43] Role of combination therapy with ACE inhibitors and calcium channel blockers in renal protection
Locatelli, F
Del Vecchio, L
Andrulli, S
Colzani, S
[J]. KIDNEY INTERNATIONAL, 2002, 62 : S53 - S60
[44] ACE inhibitors and AT-1-receptor antagonists COOPERATE in non-diabetic renal disease
Doggrell, SA
[J]. EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (07) : 1185 - 1188
[45] Treatment strategies in patients with chronic renal disease: ACE inhibitors, angiotensin receptor antagonists, or both?
Karl F. Hilgers
Jörg Dötsch
Wolfgang Rascher
Johannes F. E. Mann
[J]. Pediatric Nephrology, 2004, 19 : 956 - 961
[46] Treatment strategies in patients with chronic renal disease:: ACE inhibitors, angiotensin receptor antagonists, or both?
Hilgers, KF
Dötsch, J
Rascher, W
Mann, JFE
[J]. PEDIATRIC NEPHROLOGY, 2004, 19 (09) : 956 - 961
[47] ACE-inhibitors/amiodarone/propranololLack of efficacy: case report
[J]. Reactions Weekly, 2022, 1914 (1) : 16 - 16
[48] BexaroteneHypertriglyceridaemia and impaired renal function (first report): case report
[J]. Reactions Weekly, 2011, 1373 (1) : 10 - 10
[49] ACE-inhibitors/angiotensin receptor antagonists/diureticsHyperkalaemia and hypokalaemia: 10 case reports
[J]. Reactions Weekly, 2017, 1641 (1) : 16 - 16
[50] THE EFFECT OF DIHYDROPYRIDINE CALCIUM-ANTAGONISTS IN HYPERTENSIVE PATIENTS WITH IMPAIRED RENAL-FUNCTION
HANSSON, L
[J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 14 : S36 - S39

← 1 2 3 4 5 →